Reiter will drive new business opportunities at Calyxt to support the company’s recently announced go-to-market strategies.
Reiter is a plant-based technology and agribusiness leader focused on establishing world-class partnerships and value chains that lead to the successful commercialization of emerging technologies for start-up, early-stage and Fortune 500 companies. She will apply her expertise in international business development, acquisitions and product portfolio management in agribusiness to develop, refine and implement the overall commercial strategy for Calyxt's future products, including the prioritization of markets, customers and product types.
“Calyxt continues to build momentum with our go-to-market strategies, and the addition of Sarah to the leadership team will help us to optimize and execute on these strategies going forward,” said CEO Jim Blome in a statement.
“Her proven success in the plant-based innovation sector is an ideal match for our technology, positioning us to be even more responsive to evolving consumer, sustainability and marketplace demands."
With more than 25 years of expertise in agribusiness, Reiter most recently served as the chief commercial officer of Arcadia Biosciences Inc (NASDAQ:RKDA) where she led the company’s commercial and product portfolio strategies and sales to consumer-packaged goods companies globally.
Prior to Arcadia Biosciences, she served as the CEO of Stockton U.S.A. with oversight of the US division of the global multinational bio-ag company from inception to initial sales. She earned her Master’s Certificate in Business Analysis from the Villanova School of Continuing Education and her Bachelor’s degree from the University of California, Davis.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham